Protein-Driven Mechanism of Multiorgan Damage in COVID-19

Estrada, 2020, COVID-19 and sars-cov-2. Modeling the present, looking at the future, Phys Rep, 869, 1, 10.1016/j.physrep.2020.07.005 Gorbalenya, 2020, Coronaviridae study group of the international committee on taxonomy of viruses. The species severe acute respiratory syndrome-related coronavirus: classifying 2019-ncov and naming it sars-cov-2, Nat Microbiol, 2020, 03 Zhou, 2020, A pneumonia outbreak associated with a new coronavirus of probable bat origin, Nature, 579, 270, 10.1038/s41586-020-2012-7 Wu, 2020, A new coronavirus associated with human respiratory disease in China, Nature, 579, 265, 10.1038/s41586-020-2008-3 Jiang, 2020, Review of the clinical characteristics of coronavirus disease 2019 (COVID-19), J Gen Intern Med, 35, 545 Zhou, 2020, Coronavirus disease 2019 (COVID -19): a clinical update, Frontiers of Medicine Gupta, 2020, Extrapulmonary manifestations of COVID-19, Nat Med, 26, 1017, 10.1038/s41591-020-0968-3 Prasanna, 2020 Robba, 2020 Bourgonje, 2020, Angiotensin-converting enzyme-2 (ace2), sars-cov-2 and pathophysiology of coronavirus disease 2019 (COVID-19), J Pathol, 251, 228, 10.1002/path.5471 Alqahtani, 2020, Liver injury in COVID-19: the current evidence, United European Gastroenterology Journal, 8, 509, 10.1177/2050640620924157 Su, 2020, Renal histopathological analysis of 26 postmortem findings of patients with COVID-19 in China, Kidney Int, 98, P219, 10.1016/j.kint.2020.04.003 Hess, 2020, COVID-19-related stroke, Transl Stroke Res, 11, 322, 10.1007/s12975-020-00818-9 Li, 2020, Expression of the sars-cov-2 cell receptor gene ace2 in a wide variety of human tissues, Infect Dis Poverty, 9, 1, 10.1186/s40249-020-00662-x Hoffmann, 2020, Sars-cov-2 cell entry depends on ace2 and tmprss2 and is blocked by a clinically proven protease inhibitor, Cell, 181, 271, 10.1016/j.cell.2020.02.052 Moore, 2020, Cytokine release syndrome in severe COVID-19, Science, 368, 473, 10.1126/science.abb8925 Nile, 2020, COVID-19: pathogenesis, cytokine storm and therapeutic potential of interferons, Cytokine Growth Factor Rev, 53, 66, 10.1016/j.cytogfr.2020.05.002 Coperchini, 2020, The cytokine storm in COVID-19: an overview of the involvement of the chemokine/chemokine-receptor system, Cytokine Growth Factor Rev, 53, 25, 10.1016/j.cytogfr.2020.05.003 Chen, 2020, Detectable serum SARS-CoV-2 viral load (rnaaemia) is closely correlated with drastically elevated interleukin 6 (IL-6) level in critically ill COVID-19 patients, Clin Infect Dis Liu, 2020, Elevated plasma level of selective cytokines in COVID-19 patients reflect viral load and lung injury, Natl Sci Rev, 7, 1003, 10.1093/nsr/nwaa037 Aziz, 2020, Elevated interleukin-6 and severe COVID-19: a meta-analysis, J Med Virol, 10.1002/jmv.25948 Xu, 2020, Effective treatment of severe COVID-19 patients with tocilizumab, Proc Natl Acad Sci, 117, 10970, 10.1073/pnas.2005615117 Radbel, 2020, Use of tocilizumab for COVID-19 infection-induced cytokine release syndrome: a cautionary case report, Chest, 158, E15, 10.1016/j.chest.2020.04.024 Hedrick, 2020, COVID-19: clean up on il-6, American Journal of Respiratory Cell and Molecular Biology (ja), 63, 541, 10.1165/rcmb.2020-0277LE Campochiaro, 2020, The conundrum of interleukin-6 blockade in COVID-19, The Lancet Rheumatology, 2, e579, 10.1016/S2665-9913(20)30287-3 Hamming, 2004, Tissue distribution of ace2 protein, the functional receptor for SARS coronavirus. a first step in understanding sars pathogenesis, The Journal of Pathology: A Journal of the Pathological Society of Great Britain and Ireland, 203, 631, 10.1002/path.1570 K. To, 2004, Tissue and cellular tropism of the coronavirus associated with severe acute respiratory syndrome: an in-situ hybridization study of fatal cases, The Journal of Pathology: A Journal of the Pathological Society of Great Britain and Ireland, 202, 157, 10.1002/path.1510 Pan, 2020, No evidenceof severe acute respiratory syndrome-coronavirus 2 in semen of males recovering from coronavirus disease 2019, Fertil Steril, 113, 1135, 10.1016/j.fertnstert.2020.04.024 Manne, 2020, Platelet gene expression and function in COVID-19 patients, Blood, 10.1182/blood.2020007214 Leisman, 2020, Facing COVID-19 in the icu: vascular dysfunction, thrombosis, and dysregulated inflammation, Intensive Care Med, 46, 1105, 10.1007/s00134-020-06059-6 Sinha, 2020, Is a “cytokine storm” relevant to COVID-19?, JAMA Intern Med, 10.1001/jamainternmed.2020.3313 Sinha, 2020, Development and validation of parsimonious algorithms to classify acute respiratory distress syndrome phenotypes: a secondary analysis of randomised controlled trials, Lancet Respir Med, 8, 247, 10.1016/S2213-2600(19)30369-8 Wu, 2020, Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China, JAMA Intern Med, 180, 934, 10.1001/jamainternmed.2020.0994 F. Zhou, T. Yu, R. Du, G. Fan, Y. Liu, Z. Liu, J. Xiang, Y. Wang, B. Song, X. Gu, et al., Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study, The Lancet 395 (10229) (2020) P1054–1062. Qin, 2020, Dysregulation of immune response in patients with COVID-19 in Wuhan, China, Clin Infect Dis, 71, 762, 10.1093/cid/ciaa248 M. J. Cummings, M. R. Baldwin, D. Abrams, S. D. Jacobson, B. J. Meyer, E. M. Balough, J. G. Aaron, J. Claassen, L. E. Rabbani, J. Hastie, et al., Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York city: a prospective cohort study, The Lancet 395 (10239) (2020) P1763–1770. Mo, 2020 Famous, 2017, Acute respiratory distress syndrome subphenotypes respond differently to randomized fluid management strategy, Am J Respir Crit Care Med, 195, 331, 10.1164/rccm.201603-0645OC Calfee, 2014, Subphenotypes in acute respiratory distress syndrome: latent class analysis of data from two randomised controlled trials, Lancet Respir Med, 2, 611, 10.1016/S2213-2600(14)70097-9 Sinha, 2018, Latent class analysis of ards subphenotypes: a secondary analysis of the statins for acutely injured lungs from sepsis (sails) study, Intensive Care Med, 44, 1859, 10.1007/s00134-018-5378-3 Fan, 2018, Breaking bad: how viruses subvert the cell cycle, Front Cell Infect Microbiol, 8, 396, 10.3389/fcimb.2018.00396 Del Sol, 2010, Diseases as network perturbations, Curr Opin Biotechnol, 21, 566, 10.1016/j.copbio.2010.07.010 Furlong, 2013, Human diseases through the lens of network biology, Trends Genet, 29, 150, 10.1016/j.tig.2012.11.004 D. M. Gysi, Í. D. Valle, M. Zitnik, A. Ameli, X. Gan, O. Varol, H. Sanchez, R. M. Baron, D. Ghiassian, J. Loscalzo, et al., Network medicine framework for identifying drug repurposing opportunities for COVID-19, arXiv preprint arXiv:2004.07229 (2020). Gordon, 2020, A sars-cov-2 protein interaction map reveals targets for drug repurposing, Nature, 583, 459, 10.1038/s41586-020-2286-9 Sahni, 2015, Widespread macromolecular interaction perturbations in human genetic disorders, Cell, 161, 647, 10.1016/j.cell.2015.04.013 Shen, 2017, Proteome-scale investigation of protein allosteric regulation perturbed by somatic mutations in 7,000 cancer genomes, The American Journal of Human Genetics, 100, 5, 10.1016/j.ajhg.2016.09.020 Rajasekaran, 2017, A universal pattern in the percolation and dissipation of protein structural perturbations, The Journal of Physical Chemistry Letters, 8, 4779, 10.1021/acs.jpclett.7b02021 Jiang, 2013, Influenza a virus ns1 induces g0/g1 cell cycle arrest by inhibiting the expression and activity of rhoa protein, J Virol, 87, 3039, 10.1128/JVI.03176-12 Grimaldo, 2019, Dynamics of proteins in solution, Q Rev Biophys, 52, 1 Tkach, 2016, Communication by extracellular vesicles: where we are and where we need to go, Cell, 164, 1226, 10.1016/j.cell.2016.01.043 Guay, 2017, Exosomes as new players in metabolic organ cross-talk, Diabetes Obes Metab, 19, 137, 10.1111/dom.13027 Lee, 2018, Extracellular vesicle: an emerging mediator of intercellular crosstalk in lung inflammation and injury, Front Immunol, 9, 924, 10.3389/fimmu.2018.00924 Sluijter, 2018, Extracellular vesicles in diagnostics and therapy of the ischaemic heart: position paper from the working group on cellular biology of the heart of the european society of cardiology, Cardiovasc Res, 114, 19, 10.1093/cvr/cvx211 Nawaz, 2018, Extracellular vesicles and matrix remodeling enzymes: the emerging roles in extracellular matrix remodeling, progression of diseases and tissue repair, Cells, 7, 167, 10.3390/cells7100167 Hassanpour, 2020, 104422 Bello-Morales, 2020, Extracellular vesicles in viral spread and antiviral response, Viruses, 12, 623, 10.3390/v12060623 Kumar, 2020, Extracellular vesicles in viral replication and pathogenesis and their potential role in therapeutic intervention, Viruses, 12, 887, 10.3390/v12080887 Giannessi, 2020, The role of extracellular vesicles as allies of hiv, hcv and sars viruses, Viruses, 12, 571, 10.3390/v12050571 Zhou, 2019, Exosomes carry micrornas into neighboring cells to promote diffusive infection of Newcastle disease virus, Viruses, 11, 527, 10.3390/v11060527 Guenat, 2017, Exosomes and other extracellular vesicles in hpv transmission and carcinogenesis, Viruses, 9, 211, 10.3390/v9080211 Reyes-Ruiz, 2020, The regulation of flavivirus infection by hijacking exosome-mediated cell–cell communication: new insights on virus–host interactions, Viruses, 12, 765, 10.3390/v12070765 Kutchy, 2020, Extracellular vesicles in viral infections of the nervous system, Viruses, 12, 700, 10.3390/v12070700 Szabo, 2017, Extracellular vesicles in liver disease and potential as biomarkers and therapeutic targets, Nat Rev Gastroenterol Hepatol, 14, 455, 10.1038/nrgastro.2017.71 Nagy, 2008, Vascular permeability, vascular hyperpermeability and angiogenesis, Angiogenesis, 11, 109, 10.1007/s10456-008-9099-z Gupta, 2016, Protein entrapment in polymeric mesh: diffusion in crowded environment with fast process on short scales, Macromolecules, 49, 1941, 10.1021/acs.macromol.5b02281 Sposini, 2018, Random diffusivity from stochastic equations: comparison of two models for brownian yet non-gaussian diffusion, New J Phys, 20, 10.1088/1367-2630/aab696 Barkai, 2000, From continuous time random walks to the fractional fokker-planck equation, Physical Review E, 61, 132, 10.1103/PhysRevE.61.132 Qiu, 2020 Li, 2019, Map: model-based analysis of proteomic data to detect proteins with significant abundance changes, Cell Discovery, 5, 1, 10.1038/s41421-019-0107-9 Salih, 2014, Urinary extracellular vesicles and the kidney: biomarkers and beyond, American Journal of Physiology-Renal Physiology, 306, F1251, 10.1152/ajprenal.00128.2014 Zhang, 2016, Extracellular vesicles in diagnosis and therapy of kidney diseases, American Journal of Physiology-Renal Physiology, 311, F844, 10.1152/ajprenal.00429.2016 Karpman, 2017, Extracellular vesicles in renal disease, Nat Rev Nephrol, 13, 545, 10.1038/nrneph.2017.98 Lawrenson, 2020, COVID-19 and the eye, Ophthalmic Physiol Opt, 10.1111/opo.12708 Frühbeis, 2012, Emerging roles of exosomes in neuron–glia communication, Front Physiol, 3, 119, 10.3389/fphys.2012.00119 Rajendran, 2014, Emerging roles of extracellular vesicles in the nervous system, J Neurosci, 34, 15482, 10.1523/JNEUROSCI.3258-14.2014 Grapp, 2013, Choroid plexus transcytosis and exosome shuttling deliver folate into brain parenchyma, Nat Commun, 4, 1, 10.1038/ncomms3123 Jansen, 2017, Extracellular vesicles in cardiovascular disease: potential applications in diagnosis, prognosis, and epidemiology, Circ Res, 120, 1649, 10.1161/CIRCRESAHA.117.310752 Lawson, 2016, Microvesicles and exosomes: new players in metabolic and cardiovascular disease, J Endocrinol, 228, R57, 10.1530/JOE-15-0201 Akbar, 2019, Extracellular vesicles in metabolic disease, Diabetologia, 62, 2179, 10.1007/s00125-019-05014-5 Konadu, 2015, Association of cytokines with exosomes in the plasma of hiv-1–seropositive individuals, J Infect Dis, 211, 1712, 10.1093/infdis/jiu676 Pomatto, 2018 Milasan, 2020 Murphy, 2018, Emerging role of extracellular vesicles in musculoskeletal diseases, Mol Aspects Med, 60, 123, 10.1016/j.mam.2017.09.006 Alibhai, 2020, Cellular senescence contributes to age-dependent changes in circulating extracellular vesicle cargo and function, Aging Cell, 19, 10.1111/acel.13103 Huang, 2020, Targeting inflammation and cytokine storm in COVID-19, Pharmacol Res, 159, 105051, 10.1016/j.phrs.2020.105051 Ruscica, 2020, Clinical approach to the inflammatory etiology of cardiovascular diseases, Pharmacological Research, 104916, 10.1016/j.phrs.2020.104916 Seirafianpour, 2020, Cutaneous manifestations and considerations in COVID-19 pandemic: a systematic review, Dermatol Ther, 10.1111/dth.13986 Alexander, 2020, A rational roadmap for sars-cov-2/COVID-19 pharmacotherapeutic research and development. IUPHAR review 29, Br J Pharmacol, 10.1111/bph.15094 Bouhaddou, 2020, The global phosphorylation landscape of SARS-CoV-2 infection, Cell, 182, 685, 10.1016/j.cell.2020.06.034 Tutuncuoglu, 2020, The landscape of human cancer proteins targeted by SARS-CoV-2, Cancer Discov, 10, 916, 10.1158/2159-8290.CD-20-0559 Papathanasiou, 2020, Local anesthetics and COVID19 associated acute respiratory distress syndrome: a new therapeutic indication, Clin Res Open Access, 6 Das, 2020, In silico drug repurposing to combat COVID-19 based on pharmacogenomics of patient transcriptomic data, Research Square Meininger, 2017, Safety and efficacy of ozanezumab in patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled, phase 2 trial, The Lancet Neurology, 16, 208, 10.1016/S1474-4422(16)30399-4 Ríos, 2018, A pharmacological update of ellagic acid, Planta Med, 84, 1068, 10.1055/a-0633-9492 Wang, 1998, Inhibition of eukaryote serine/threonine-specific protein kinases by piceatannol, Planta Med, 64, 195, 10.1055/s-2006-957407 Piñero, 2020, The disgenet knowledge platform for disease genomics: 2019 update, Nucleic Acids Res, 48, D845 Menche, 2015, Uncovering disease-disease relationships through the incomplete interactome, Science, 347, 10.1126/science.1257601 Uhlén, 2015, Tissue-based map of the human proteome, Science, 347, 10.1126/science.1260419 Estrada, 2020, Fractional diffusion on the human proteome as an alternative to the multi-organ damage of SARS-CoV-2, Chaos, 30, 10.1063/5.0015626 Mainardi, 2010 Griffith, 2013, Dgidb: mining the druggable genome, Nat Methods, 10, 1209, 10.1038/nmeth.2689 Keerthikumar, 2016, Exocarta: a web-based compendium of exosomal cargo, J Mol Biol, 428, 688, 10.1016/j.jmb.2015.09.019